JPS5549374A - Manufacture of furanyllbenzazole - Google Patents

Manufacture of furanyllbenzazole

Info

Publication number
JPS5549374A
JPS5549374A JP12742779A JP12742779A JPS5549374A JP S5549374 A JPS5549374 A JP S5549374A JP 12742779 A JP12742779 A JP 12742779A JP 12742779 A JP12742779 A JP 12742779A JP S5549374 A JPS5549374 A JP S5549374A
Authority
JP
Japan
Prior art keywords
furanyllbenzazole
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12742779A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0153276B2 (cg-RX-API-DMAC7.html
Inventor
Gugurierumetsutei Reonarudo
Riyuutei Kurisuteian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of JPS5549374A publication Critical patent/JPS5549374A/ja
Publication of JPH0153276B2 publication Critical patent/JPH0153276B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP12742779A 1978-10-04 1979-10-04 Manufacture of furanyllbenzazole Granted JPS5549374A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1030478 1978-10-04

Publications (2)

Publication Number Publication Date
JPS5549374A true JPS5549374A (en) 1980-04-09
JPH0153276B2 JPH0153276B2 (cg-RX-API-DMAC7.html) 1989-11-13

Family

ID=4361752

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12742779A Granted JPS5549374A (en) 1978-10-04 1979-10-04 Manufacture of furanyllbenzazole

Country Status (5)

Country Link
EP (1) EP0010063B1 (cg-RX-API-DMAC7.html)
JP (1) JPS5549374A (cg-RX-API-DMAC7.html)
BR (1) BR7906368A (cg-RX-API-DMAC7.html)
DE (1) DE2964427D1 (cg-RX-API-DMAC7.html)
ES (1) ES484676A1 (cg-RX-API-DMAC7.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2904829A1 (de) * 1979-02-08 1980-08-14 Bayer Ag Verfahren zur herstellung von benzimidazolylbenzofuran
US4542222A (en) * 1980-12-29 1985-09-17 Ciba-Ceigy Corporation Benzimidazoles
JPS615071A (ja) * 1984-06-15 1986-01-10 Fuji Photo Film Co Ltd ベンゾオキサゾ−ル誘導体
GB8417194D0 (en) * 1984-07-05 1984-08-08 Boots Co Plc Therapeutic agents
US4581457A (en) * 1984-09-21 1986-04-08 American Home Products Corporation Heterocyclic sulfonamides
DE4129603A1 (de) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
IT1272917B (it) * 1995-01-20 1997-07-01 3V Sigma Spa Derivati di benzossazolo,loro uso come filtri solari e composizioni cosmetiche che li contengono
AU773097B2 (en) * 1996-07-03 2004-05-13 Beckman Coulter, Inc. Automatic chemistry analyser
NZ514403A (en) 1999-12-27 2002-10-25 Japan Tobacco Inc Fused-ring compounds and use thereof as drugs
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
AU2002346216B2 (en) * 1999-12-27 2005-12-08 Japan Tobacco Inc. Fused cyclic compounds and medicinal use thereof
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
AR035543A1 (es) * 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
EP1651631A1 (en) 2003-08-01 2006-05-03 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
UY28758A1 (es) 2004-02-20 2005-09-30 Boehringer Ingelheim Int Inhibidores de polimerasa viral
JP5015154B2 (ja) 2005-08-12 2012-08-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウイルスポリメラーゼインヒビター
JP2013500267A (ja) * 2009-07-23 2013-01-07 ヴァンダービルト ユニバーシティー ｍＧＬｕＲ４増強剤としての置換されたベンゾイミダゾールスルホンアミド類および置換されたインドールスルホンアミド類
EP2797597B1 (en) 2011-12-28 2020-02-26 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
EP2797416B1 (en) 2011-12-28 2017-08-09 Global Blood Therapeutics, Inc. Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
ES2864707T3 (es) 2013-03-15 2021-10-14 Global Blood Therapeutics Inc Compuestos y usos de los mismos para la modulación de la hemoglobina
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
KR102280614B1 (ko) 2013-03-15 2021-07-21 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
BR112015021982B1 (pt) 2013-03-15 2022-12-13 Global Blood Therapeutics, Inc Compostos e seus usos para a modulação de hemoglobina
WO2014145040A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
ES2860648T5 (es) 2014-02-07 2024-11-27 Global Blood Therapeutics Inc Polimorfos cristalinos de la base libre de 2-hidroxi-6-((2-(1-isopropil-1H-pirazol-5-il)piridin-3-il)metoxi)benzaldehído
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
PT3383392T (pt) 2015-12-04 2025-09-01 Global Blood Therapeutics Inc Regimes de administração do 2-hidroxi-6-((2-(1-isopropil- 1h-pirazol-5-il)piridin-3-il)metoxi)benzaldeído
AR108435A1 (es) 2016-05-12 2018-08-22 Global Blood Therapeutics Inc Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
ES2966707T3 (es) 2018-10-01 2024-04-23 Global Blood Therapeutics Inc Moduladores de la hemoglobina para el tratamiento de la drepanocitosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4828464A (cg-RX-API-DMAC7.html) * 1971-08-13 1973-04-14
JPS4987653A (cg-RX-API-DMAC7.html) * 1972-12-18 1974-08-22

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4828464A (cg-RX-API-DMAC7.html) * 1971-08-13 1973-04-14
JPS4987653A (cg-RX-API-DMAC7.html) * 1972-12-18 1974-08-22

Also Published As

Publication number Publication date
EP0010063A2 (de) 1980-04-16
DE2964427D1 (en) 1983-02-03
EP0010063A3 (en) 1980-09-03
ES484676A1 (es) 1980-05-16
BR7906368A (pt) 1980-05-27
JPH0153276B2 (cg-RX-API-DMAC7.html) 1989-11-13
EP0010063B1 (de) 1982-12-29

Similar Documents

Publication Publication Date Title
JPS5549374A (en) Manufacture of furanyllbenzazole
JPS54109932A (en) Manufacture of fluorobenzol
GB2015992B (en) Manufacture of para-nitro-diphenylamines
JPS54132575A (en) Manufacture of tetrahydrobenzoxocin
JPS54109924A (en) Manufacture of silylphosphate
JPS54128534A (en) Manufacture of nitrodiarylamines
JPS5533490A (en) Manufacture of 44fluoroo33phenoxyytoluene
JPS54100322A (en) Manufacture of nnacyltaurine
JPS54157554A (en) Manufacture of 66haloopregnane
JPS54131600A (en) Manufacture of borazin
JPS54122243A (en) Manufacture of 22nitrobenzaldehyde
JPS54151911A (en) Manufacture of chloracetylchloride
JPS5524192A (en) Manufacture of azaspirodecane
JPS54135737A (en) Manufacture of trifluoromethylphenols
IL58568A (en) Manufacture of 5-cyano-4-methyloxazole
JPS54144323A (en) Manufacture of ppxylene
JPS54148749A (en) Manufacture of monoarylthiourea
JPS54163548A (en) Manufacture of 22oxyiminophenylacetonitrile
IL57174A (en) Manufacture of alpha-chloroacetoacetamides
JPS54128530A (en) Manufacture of ppaminoodiphenylamine
JPS54117412A (en) Manufacture of 22nitroo22methyll11propanol
JPS54112858A (en) Manufacture of 22pyrrolidone
JPS5515462A (en) Manufacture of hexahydropyrimidyll44ether
JPS55105698A (en) Manufacture of 11oxophospholeneedelta3
JPS54144324A (en) Manufacture of ppxylene